Copyright: ©Author(s) 2026.
World J Stem Cells. Sep 26, 2026; 18(9): 124540
Published online Sep 26, 2026. doi: 10.4252/wjsc.124540
Published online Sep 26, 2026. doi: 10.4252/wjsc.124540
Figure 6 Mediator complex subunit 12 mutation mediated the inhibitory effect of cancer cells on the killing and chemotactic abilities of CD8+ T cells.
After co-culture of NCI-H322 and PC9 cells with CD8+ T cells, the following parameters of CD8+ T cells or tumor cells were analyzed. A: Transwell assay was performed to assess the migratory capacity of CD8+ T cells toward tumor cells; B: The expression of interferon-γ, tumor necrosis factor-α, perforin, and granzyme B in CD8+ T cells were measured by enzyme-linked immunosorbent assay; C: Flow cytometry was used to detect the percentage of programmed cell death 1-positive CD8+ T cells; D: The level of lactate dehydrogenase (LDH) in tumor cells was measured by LDH Cytotoxicity Assay Kit to evaluate the cytotoxic activity of CD8+ T cells. Data are presented as mean ± SD. aP < 0.05, bP < 0.01, cP < 0.001. All experiments were repeated 3 times. IFN: Interferon; TNF: Tumor necrosis factor.
- Citation: Yang Y, Zhong JL, Liu JY. MED12 mutation activates Notch signaling to enhance cancer stemness and suppress CD8+ T cell cytotoxicity in lung cancer. World J Stem Cells 2026; 18(9): 124540
- URL: https://www.wjgnet.com/1948-0210/full/v18/i9/124540.htm
- DOI: https://dx.doi.org/10.4252/wjsc.124540